SCHEMBL31201176

SCHEMBL31201176

CCC(CC)Nc1cc(NCCc2ccccc2)c2nnc(C(C)C)n2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA2D1 P54289 1/20 0.41
▸ CDK7 P50613 2/20 0.38
▸ HTR7 P34969 6/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ BRD4 O60885 2/20 0.34
▸ CCNT1 O60563 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CCNH P51946 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ADORA2A P29274 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ TNKS O95271 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201218 0.94 CCNK (0.39) CACNA2D1CDK7HTR7SMN1; SMN2RECQL
SCHEMBL31201418 0.91 GSK3B (0.35) CACNA2D1CDK7CDK2CDK9TNKS
SCHEMBL31201302 0.90 CDK2 (0.37) CACNA2D1CDK7PIM1CCNT1CDK2
SCHEMBL31201492 0.89 CDK7 (0.45) CACNA2D1CDK7SMN1; SMN2BRD4CCNT1
SCHEMBL31201336 0.86 GABRA1 (0.45) CACNA2D1LMNANPC1RAB9A
SCHEMBL31201363 0.85 GSK3B (0.39) CACNA2D1CDK7
SCHEMBL31201280 0.84 CACNA2D1 (0.45) CACNA2D1CDK7HTR7PIM1SMN1; SMN2
SCHEMBL31201375 0.84 CDK7 (0.53) CDK7SMN1; SMN2CCNT1CDK2CDK9
SCHEMBL31201350 0.83 GABRA1 (0.33) CDK7BRD4CCNT1CDK2CDK9
SCHEMBL31201150 0.83 TYK2 (0.36) CACNA2D1CDK7RECQLBRD4CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP claimed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO claimed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
Send feedback